Jonathan Barratt, PhD, FRCP - Redefining Hope: The IgA Nephropathy Journey

Visit https://www.peervoice.com/GPM860 to view the entire programme with slides. After completing “Jonathan Barratt, PhD, FRCP - Redefining Hope: The IgA Nephropathy Journey”, participants will be able to: Summarize the patient perspective of disease burden and unmet needs in the management of immunoglobulin A nephropathy (IgAN); Recognize the clinical significance of established clinical trial endpoints including estimated glomerular filtration rate (eGFR); and Conceptualize the current and emerging therapeutic developments in terms of the challenges they aim to address in the management of IgAN.